Zavante Therapeutics Funding: $65M Raised, Series A (2016)
Zavante Therapeutics is based in San Diego. It has raised $65M in total funding. Latest round: Series A.
Zavante Therapeutics funding overview
Zavante Therapeutics is based in San Diego. Zavante Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2016. The round record for Zavante Therapeutics runs through 2016; nothing later has been disclosed. Investors on record include Frazier Healthcare Partners, Longitude Capital. 2 distinct backers are named across the disclosed rounds.
Zavante Therapeutics at a glance
Total raised
$65M
Latest round
Series A
Latest round date
March 2016
Headquarters
San Diego
Notable investors
Frazier Healthcare Partners, Longitude Capital
Frequently asked about Zavante Therapeutics funding
How much has Zavante Therapeutics raised?
Zavante Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Zavante Therapeutics?
Frazier Healthcare Partners, Longitude Capital are named among the investors backing Zavante Therapeutics.
What was the latest Zavante Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2016.
Where is Zavante Therapeutics based?
Zavante Therapeutics is based in San Diego.
When did Zavante Therapeutics last raise?
The last disclosed Zavante Therapeutics round closed in March 2016 at Series A.
Zavante Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.
